Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Zeng, Jun ^a   Yang, Xudan ^b   Cheng, Lin ^a   Liu, Rui ^a   Lei, Yunlong ^a   Dong, Dandan ^b   Li, Fanghua ^b   Lau, Quek Choon ^c   Deng, Longfei ^a   Nice, Edouard C ^d   Xie, Ke ^b   Huang, Canhua ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c DEPARTMENT OF ELECTRONICS AND COMPUTER ENGINEERING   (Singapore)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Colorectal carcinoma; CXCL14; Disease free survival; Overall survival; Prognosis

Indexed keywords

BROXURIDINE; CXCL14 CHEMOKINE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; RECURRENT DISEASE; TISSUE DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHEMOKINES, CXC; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; UP-REGULATION;

EID: 84871911257     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-6     Document Type: Article

References (40)

1. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772. 10.1016/S0140-6736(03)13412-5, 12781535.
2. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009, 10:353-358.
3. Wang H, Huang H, Li W, Jin X, Zeng J, Liu Y, et al. Nuclear localization of 14-3-3 epsilon inversely correlates with poor long-term survival of patients with colorectal cancer. J Surg Oncol 2011, 106:224-231.
4. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999, 17:1499-1507.
5. Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Tumour-immune cell interactions modulated by chemokines. Expert Opin Biol Ther 2008, 8:269-290. 10.1517/14712598.8.3.269, 18294099.
6. Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, et al. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res 2005, 11:490-497.
7. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283:R7-R28.
8. Murphy PM. Chemokine receptors: cloning strategies. Methods 1996, 10:104-118. 10.1006/meth.1996.0084, 8812650.
9. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003, 200:448-464. 10.1002/path.1400, 12845612.
10. Shimonaka M, Katagiri K, Nakayama T, Fujita N, Tsuruo T, Yoshie O, et al. Rap1 Translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 2003, 161:417-427. 10.1083/jcb.200301133, 2172897, 12707305.
11. Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A, et al. CXCL12/SDF1 Expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 2009, 45:2579-2587. 10.1016/j.ejca.2009.06.026, 19646861.
12. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005, 23:2744-2753.
13. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K, Azam M, et al. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 1999, 255:703-706. 10.1006/bbrc.1999.0257, 10049774.
14. Frederick MJ, Henderson Y, Xu X, Deavers MT, Sahin AA, Wu H, et al. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 2000, 156:1937-1950. 10.1016/S0002-9440(10)65067-5, 1850081, 10854217.
15. Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T, et al. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA 2009, 106:3414-3419. 10.1073/pnas.0813144106, 2651265, 19218429.
16. Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, et al. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 2009, 69:2375-2383. 10.1158/0008-5472.CAN-08-3359, 2760349, 19276362.
17. Ozawa S, Kato Y, Kubota E, Hata RI, Ozawa S, Kato Y, Kubota E, Hata RI. BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse. Biomedical Res 2009, 30:315-318.
18. Shurin GV, Ferris RL, Tourkova IL, Perez L, Lokshin A, Balkir L, et al. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 2005, 174:5490-5498.
19. Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, et al. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 2008, 259:209-217. 10.1016/j.canlet.2007.10.021, 18054154.
20. Oler G, Camacho CP, Hojaij FC, Michaluart P, Riggins GJ, Cerutti JM. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis. Clin Cancer Res 2008, 14:4735-4742. 10.1158/1078-0432.CCR-07-4372, 2742302, 18676742.
21. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004, 23:1669-1678. 10.1038/sj.emboj.7600170, 391075, 15014433.
22. Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K, et al. Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci 2009, 100:2202-2209. 10.1111/j.1349-7006.2009.01281.x, 19673887.
23. Liu R, Li Z, Bai S, Zhang H, Tang M, Lei Y, et al. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol Cell Proteomics 2009, 8:70-85. 10.1074/mcp.M800195-MCP200, 18723843.
24. Kuang HB, Chen Q, Zhang Y, Zhang L, Peng HY, Ning LN, et al. The cytokine gene CXCL14 restricts human trophoblast cell invasion by suppressing gelatinase activity. Endocrinology 2009, 150:5596-5605. 10.1210/en.2009-0570, 19833716.
25. Wang K, Liu R, Li J, Mao J, Lei Y, Wu J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy 2011, 7:966-78. 10.4161/auto.7.9.15863, 21610320.
26. Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie K, et al. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics 2011, 10:M110 005397. 3205852, 21622897.
27. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002, 94:2511-2516. 10.1002/cncr.10492, 12015777.
28. Li Z, Huang C, Bai S, Pan X, Zhou R, Wei Y, et al. Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach. Int J Cancer 2008, 123:2377-2383. 10.1002/ijc.23808, 18729184.
29. Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer 2006, 6:99-106. 10.1038/nrc1802, 16491069.
30. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32. 10.1016/j.ccr.2004.06.010, 15261139.
31. Harpole DH, Herndon JE, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995, 55:51-56.
32. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004, 54:295-308. 10.3322/canjclin.54.6.295, 15537574.
33. Washington MK. Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 2008, 132:1600-1607.
34. Sun H, Chua MS, Yang D, Tsalenko A, Peter BJ, So S. Antibody arrays identify potential diagnostic markers of hepatocellular carcinoma. Biomark Insights 2008, 3:1-18. 2688354, 19578489.
35. Wu Y, Li YY, Matsushima K, Baba T, Mukaida N. CCL3-CCR5 Axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol 2008, 181:6384-6393.
36. Singh S, Singh UP, Grizzle WE, Lillard JW. CXCL12-CXCR4 Interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 2004, 84:1666-1676. 10.1038/labinvest.3700181, 15467730.
37. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572. 10.1038/nrc865, 12154349.
38. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 2001, 61:5697-5702.
39. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56. 10.1038/35065016, 11242036.
40. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458. 10.1038/nrc1098, 12778135.